Joel Greenblatt's CLX Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 274,454 shares of The Clorox Company (CLX) worth $33.84 M, representing 0.15% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Joel Greenblatt has maintained a long-term strategic position in CLX, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2017, adding 267,870 shares. Largest reduction occurred in Q1 2015, reducing 299,856 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's The Clorox Company (CLX) Holding Value Over Time
Track share changes against reported price movement
Quarterly The Clorox Company (CLX) Trades by Joel Greenblatt
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +24,973 | Add 0.00% | 24,972 | $83.13 |
| Q3 2013 | +32,902 | Add 131.76% | 57,874 | $81.71 |
| Q4 2013 | -16,031 | Reduce 27.70% | 41,843 | $92.75 |
| Q1 2014 | +163,788 | Add 391.43% | 205,631 | $88.01 |
| Q2 2014 | +78,237 | Add 38.05% | 283,868 | $91.40 |
| Q3 2014 | -25,559 | Reduce 9.00% | 258,309 | $96.04 |
| Q4 2014 | +217,658 | Add 84.26% | 475,967 | $104.21 |
| Q1 2015 | -299,856 | Reduce 63.00% | 176,111 | $110.39 |
| Q2 2015 | +89,227 | Add 50.67% | 265,338 | $104.02 |
| Q3 2015 | +1,668 | Add 0.63% | 267,006 | $115.53 |
| Q4 2015 | -229,009 | Reduce 85.77% | 37,997 | $126.83 |
| Q1 2016 | -34,662 | Reduce 91.22% | 3,335 | $125.94 |
| Q3 2016 | +103,999 | Add 3118.41% | 107,334 | $125.18 |
| Q4 2016 | -100,272 | Reduce 93.42% | 7,062 | $120.08 |
| Q1 2017 | -7,062 | Sold Out | 7,062 | $0.00 |
| Q2 2017 | +5,273 | New Buy | 5,273 | $133.32 |
| Q3 2017 | +267,870 | Add 5080.03% | 273,143 | $131.91 |
| Q4 2017 | -121,304 | Reduce 44.41% | 151,839 | $148.74 |
| Q1 2018 | -151,839 | Sold Out | 151,839 | $0.00 |
| Q3 2018 | +111,234 | New Buy | 111,234 | $150.41 |
| Q4 2018 | -66,205 | Reduce 59.52% | 45,029 | $154.15 |
| Q1 2019 | -5,175 | Reduce 11.49% | 39,854 | $160.46 |
| Q2 2019 | -30,502 | Reduce 76.53% | 9,352 | $153.12 |
| Q3 2019 | +12,490 | Add 133.55% | 21,842 | $151.86 |
| Q4 2019 | -7,137 | Reduce 32.68% | 14,705 | $153.55 |
| Q1 2020 | -12,579 | Reduce 85.54% | 2,126 | $173.10 |
| Q2 2020 | +6,949 | Add 326.86% | 9,075 | $219.39 |
| Q3 2020 | +26,005 | Add 286.56% | 35,080 | $210.18 |
| Q4 2020 | +7,197 | Add 20.52% | 42,277 | $201.93 |
| Q1 2021 | -20,456 | Reduce 48.39% | 21,821 | $192.89 |
| Q2 2021 | -17,706 | Reduce 81.14% | 4,115 | $179.83 |
| Q3 2021 | -4,115 | Sold Out | 4,115 | $0.00 |
| Q4 2021 | +1,235 | New Buy | 1,235 | $174.09 |
| Q1 2022 | +3,962 | Add 320.81% | 5,197 | $139.12 |
| Q2 2022 | -915 | Reduce 17.61% | 4,282 | $141.06 |
| Q3 2022 | -1,233 | Reduce 28.79% | 3,049 | $128.24 |
| Q4 2022 | +191 | Add 6.26% | 3,240 | $140.33 |
| Q1 2023 | +1,553 | Add 47.93% | 4,793 | $158.24 |
| Q2 2023 | +15,387 | Add 321.03% | 20,180 | $159.04 |
| Q3 2023 | +15,759 | Add 78.09% | 35,939 | $131.06 |
| Q4 2023 | -31,663 | Reduce 88.10% | 4,276 | $142.59 |
| Q1 2024 | +21,603 | Add 505.22% | 25,879 | $153.11 |
| Q2 2024 | -133 | Reduce 0.51% | 25,746 | $136.47 |
| Q3 2024 | -424 | Reduce 1.65% | 25,322 | $162.91 |
| Q4 2024 | +36,742 | Add 145.10% | 62,064 | $162.41 |
| Q1 2025 | -25,191 | Reduce 40.59% | 36,873 | $147.25 |
| Q2 2025 | +89,307 | Add 242.20% | 126,180 | $120.07 |
| Q3 2025 | +148,274 | Add 117.51% | 274,454 | $123.30 |
Joel Greenblatt's The Clorox Company Investment FAQs
Joel Greenblatt first purchased The Clorox Company (CLX) in Q2 2013, acquiring 24,972 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held The Clorox Company (CLX) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt's largest addition to The Clorox Company (CLX) was in Q3 2017, adding 273,143 shares worth $36.03 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 274,454 shares of The Clorox Company (CLX), valued at approximately $33.84 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, The Clorox Company (CLX) represents approximately 0.15% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt's peak holding in The Clorox Company (CLX) was 475,967 shares, as reported at the end of Q4 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.